Compile Data Set for Download or QSAR
Report error Found 84 Enz. Inhib. hit(s) with all data for entry = 11342
TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 608724BDBM608724(US11697650, Compound 1 | US11697650, Example 35)
Affinity DataIC50: 5nMAssay Description:The following assay concentrations and times were used: 3 ng BCL-2, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled acce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/11/2023
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 608408BDBM608408(US11697650, Compound 4 | US11697650, Example 2 | N...)
Affinity DataIC50: 5nMAssay Description:The following assay concentrations and times were used: 3 ng BCL-2, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled acce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/11/2023
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 608725BDBM608725(US11697650, Compound 8 | US11697650, Example 37)
Affinity DataIC50: 5nMAssay Description:The following assay concentrations and times were used: 3 ng BCL-2, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled acce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/11/2023
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 608413BDBM608413(US11697650, Compound 11 | US11697650, Example 5 | ...)
Affinity DataIC50: 5nMAssay Description:The following assay concentrations and times were used: 3 ng BCL-2, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled acce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/11/2023
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 608716BDBM608716(US11697650, Compound 9 | US11697650, Example 25)
Affinity DataIC50: 5nMAssay Description:The following assay concentrations and times were used: 3 ng BCL-2, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled acce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/11/2023
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 608700BDBM608700(US11697650, Compound 31 | US11697650, Example 9 | ...)
Affinity DataIC50: 5nMAssay Description:The following assay concentrations and times were used: 3 ng BCL-2, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled acce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/11/2023
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 608731BDBM608731(US11697650, Compound 48 | US11697650, Example 42)
Affinity DataIC50: 5nMAssay Description:The following assay concentrations and times were used: 3 ng BCL-2, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled acce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/11/2023
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 608719BDBM608719(US11697650, Compound 7 | US11697650, Example 28)
Affinity DataIC50: 5nMAssay Description:The following assay concentrations and times were used: 3 ng BCL-2, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled acce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/11/2023
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 608702BDBM608702(US11697650, Compound 33 | US11697650, Example 11)
Affinity DataIC50: 5nMAssay Description:The following assay concentrations and times were used: 3 ng BCL-2, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled acce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/11/2023
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 608721BDBM608721(US11697650, Compound 6 | US11697650, Example 31)
Affinity DataIC50: 5nMAssay Description:The following assay concentrations and times were used: 3 ng BCL-2, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled acce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/11/2023
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 608704BDBM608704(US11697650, Compound 3 | US11697650, Example 13)
Affinity DataIC50: 5nMAssay Description:The following assay concentrations and times were used: 3 ng BCL-2, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled acce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/11/2023
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 608720BDBM608720(US11697650, Compound 2 | US11697650, Example 30)
Affinity DataIC50: 5nMAssay Description:The following assay concentrations and times were used: 3 ng BCL-2, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled acce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/11/2023
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 608706BDBM608706(US11697650, Compound 5 | US11697650, Example 15)
Affinity DataIC50: 5nMAssay Description:The following assay concentrations and times were used: 3 ng BCL-2, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled acce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/11/2023
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 608406BDBM608406(US11697650, Compound 15 | US11697650, Example 1 | ...)
Affinity DataIC50: 7.5nMAssay Description:The following assay concentrations and times were used: 3 ng BCL-2, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled acce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/11/2023
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 608711BDBM608711(US11697650, Compound 37 | US11697650, Example 20)
Affinity DataIC50: 7.5nMAssay Description:The following assay concentrations and times were used: 3 ng BCL-2, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled acce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/11/2023
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 608726BDBM608726(US11697650, Compound 12 | US11697650, Example 38)
Affinity DataIC50: 7.5nMAssay Description:The following assay concentrations and times were used: 3 ng BCL-2, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled acce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/11/2023
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 608410BDBM608410(US11697650, Compound 14 | US11697650, Example 3 | ...)
Affinity DataIC50: 7.5nMAssay Description:The following assay concentrations and times were used: 3 ng BCL-2, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled acce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/11/2023
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 608703BDBM608703(US11697650, Compound 19 | US11697650, Example 12)
Affinity DataIC50: 7.5nMAssay Description:The following assay concentrations and times were used: 3 ng BCL-2, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled acce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/11/2023
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 608727BDBM608727(US11697650, Compound 43 | US11697650, Example 41)
Affinity DataIC50: 7.5nMAssay Description:The following assay concentrations and times were used: 3 ng BCL-2, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled acce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/11/2023
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 608411BDBM608411(US11697650, Compound 20 | US11697650, Example 4 | ...)
Affinity DataIC50: 7.5nMAssay Description:The following assay concentrations and times were used: 3 ng BCL-2, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled acce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/11/2023
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 608723BDBM608723(US11697650, Compound 13 | US11697650, Example 33)
Affinity DataIC50: 7.5nMAssay Description:The following assay concentrations and times were used: 3 ng BCL-2, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled acce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/11/2023
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 608715BDBM608715(US11697650, Compound 39 | US11697650, Example 24)
Affinity DataIC50: 7.5nMAssay Description:The following assay concentrations and times were used: 3 ng BCL-2, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled acce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/11/2023
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 608722BDBM608722(US11697650, Compound 10 | US11697650, Example 32)
Affinity DataIC50: 7.5nMAssay Description:The following assay concentrations and times were used: 3 ng BCL-2, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled acce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/11/2023
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 608701BDBM608701(US11697650, Compound 32 | US11697650, Example 10)
Affinity DataIC50: 30nMAssay Description:The following assay concentrations and times were used: 3 ng BCL-2, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled acce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/11/2023
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 608709BDBM608709(US11697650, Compound 35 | US11697650, Example 18)
Affinity DataIC50: 30nMAssay Description:The following assay concentrations and times were used: 3 ng BCL-2, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled acce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/11/2023
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 608717BDBM608717(US11697650, Compound 23 | US11697650, Example 26)
Affinity DataIC50: 30nMAssay Description:The following assay concentrations and times were used: 3 ng BCL-2, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled acce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/11/2023
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 608708BDBM608708(US11697650, Compound 24 | US11697650, Example 17)
Affinity DataIC50: 30nMAssay Description:The following assay concentrations and times were used: 3 ng BCL-2, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled acce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/11/2023
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 608710BDBM608710(US11697650, Compound 18 | US11697650, Example 19 |...)
Affinity DataIC50: 30nMAssay Description:The following assay concentrations and times were used: 3 ng BCL-2, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled acce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/11/2023
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 608712BDBM608712(US11697650, Compound 38 | US11697650, Example 21)
Affinity DataIC50: 30nMAssay Description:The following assay concentrations and times were used: 3 ng BCL-2, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled acce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/11/2023
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 608698BDBM608698(US11697650, Compound 17 | US11697650, Example 7 | ...)
Affinity DataIC50: 30nMAssay Description:The following assay concentrations and times were used: 3 ng BCL-2, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled acce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/11/2023
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 608707BDBM608707(US11697650, Compound 16 | US11697650, Example 16)
Affinity DataIC50: 30nMAssay Description:The following assay concentrations and times were used: 3 ng BCL-2, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled acce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/11/2023
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 608729BDBM608729(US11697650, Compound 46 | US11697650, Example 42)
Affinity DataIC50: 30nMAssay Description:The following assay concentrations and times were used: 3 ng BCL-2, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled acce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/11/2023
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 608697BDBM608697(US11697650, Compound 21 | US11697650, Example 6 | ...)
Affinity DataIC50: 30nMAssay Description:The following assay concentrations and times were used: 3 ng BCL-2, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled acce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/11/2023
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 608728BDBM608728(US11697650, Compound 45 | US11697650, Example 42)
Affinity DataIC50: 30nMAssay Description:The following assay concentrations and times were used: 3 ng BCL-2, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled acce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/11/2023
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 608718BDBM608718(US11697650, Compound 27 | US11697650, Example 27)
Affinity DataIC50: 50nMAssay Description:The following assay concentrations and times were used: 3 ng BCL-2, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled acce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/11/2023
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 608732BDBM608732(US11697650, Compound 49 | US11697650, Example 42)
Affinity DataIC50: 50nMAssay Description:The following assay concentrations and times were used: 3 ng BCL-2, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled acce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/11/2023
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 608699BDBM608699(US11697650, Compound 30 | US11697650, Example 8 | ...)
Affinity DataIC50: 50nMAssay Description:The following assay concentrations and times were used: 3 ng BCL-2, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled acce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/11/2023
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 608733BDBM608733(US11697650, Compound 50 | US11697650, Example 42)
Affinity DataIC50: 50nMAssay Description:The following assay concentrations and times were used: 3 ng BCL-2, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled acce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/11/2023
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 608714BDBM608714(US11697650, Compound 22 | US11697650, Example 23)
Affinity DataIC50: 50nMAssay Description:The following assay concentrations and times were used: 3 ng BCL-2, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled acce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/11/2023
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 608705BDBM608705(US11697650, Compound 34 | US11697650, Example 14)
Affinity DataIC50: 50nMAssay Description:The following assay concentrations and times were used: 3 ng BCL-2, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled acce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/11/2023
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 608713BDBM608713(US11697650, Compound 26 | US11697650, Example 22)
Affinity DataIC50: 50nMAssay Description:The following assay concentrations and times were used: 3 ng BCL-2, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled acce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/11/2023
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 608730BDBM608730(US11697650, Compound 47 | US11697650, Example 42)
Affinity DataIC50: 50nMAssay Description:The following assay concentrations and times were used: 3 ng BCL-2, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled acce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/11/2023
Entry Details
US Patent

TargetBcl-2-like protein 1(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 608406BDBM608406(US11697650, Compound 15 | US11697650, Example 1 | ...)
Affinity DataIC50: 2.00E+3nMAssay Description:The following assay concentrations and times were used: 10.5 ng BCL-XL, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/11/2023
Entry Details
US Patent

TargetBcl-2-like protein 1(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 608724BDBM608724(US11697650, Compound 1 | US11697650, Example 35)
Affinity DataIC50: 2.00E+3nMAssay Description:The following assay concentrations and times were used: 10.5 ng BCL-XL, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/11/2023
Entry Details
US Patent

TargetBcl-2-like protein 1(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 608710BDBM608710(US11697650, Compound 18 | US11697650, Example 19 |...)
Affinity DataIC50: 2.00E+3nMAssay Description:The following assay concentrations and times were used: 10.5 ng BCL-XL, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/11/2023
Entry Details
US Patent

TargetBcl-2-like protein 1(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 608408BDBM608408(US11697650, Compound 4 | US11697650, Example 2 | N...)
Affinity DataIC50: 2.00E+3nMAssay Description:The following assay concentrations and times were used: 10.5 ng BCL-XL, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/11/2023
Entry Details
US Patent

TargetBcl-2-like protein 1(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 608725BDBM608725(US11697650, Compound 8 | US11697650, Example 37)
Affinity DataIC50: 2.00E+3nMAssay Description:The following assay concentrations and times were used: 10.5 ng BCL-XL, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/11/2023
Entry Details
US Patent

TargetBcl-2-like protein 1(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 608413BDBM608413(US11697650, Compound 11 | US11697650, Example 5 | ...)
Affinity DataIC50: 2.00E+3nMAssay Description:The following assay concentrations and times were used: 10.5 ng BCL-XL, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/11/2023
Entry Details
US Patent

TargetBcl-2-like protein 1(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 608726BDBM608726(US11697650, Compound 12 | US11697650, Example 38)
Affinity DataIC50: 2.00E+3nMAssay Description:The following assay concentrations and times were used: 10.5 ng BCL-XL, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/11/2023
Entry Details
US Patent

TargetBcl-2-like protein 1(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 608700BDBM608700(US11697650, Compound 31 | US11697650, Example 9 | ...)
Affinity DataIC50: 2.00E+3nMAssay Description:The following assay concentrations and times were used: 10.5 ng BCL-XL, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/11/2023
Entry Details
US Patent

Displayed 1 to 50 (of 84 total ) | Next | Last >>
Jump to: